TMCnet News
Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models"(PR Web Via Acquire Media NewsEdge) Chester, NJ (PRWEB) August 21, 2014 Pursuit Solutions (http://www.pursuit-solutions.com), a provider of personal selling optimization technology and services for Life Sciences sales and marketing organizations, announced the publication of "Grading Pharma's Use of New Commercial Sales Models" by Peter Robinson, co-founder and head of Measurement & Analytics. The article examines some innovative models used to improve sales and marketing yield that are being tested in the pharmaceutical market. Robinson grades the industry on its progress against each model and proposes solutions to close remaining gaps. To view the full article, visit http://www.pm360online.com/grading-pharmas-use-of-new-commercial-sales-models/. About Pursuit Solutions Pursuit Solutions provides sales and marketing optimization solutions for Life Sciences. Its flagship product, ClearSky, provides the pharmaceutical Field Force with an intuitive and powerful Closed-Loop Marketing (CLM) and Sales Force Automation (SFA) solution, that in concert with the client's Multi-Channel Marketing (MCM) system enables the user to be aware of marketing touch-points, receive data-driven Interactive Visual Aid (IVA) and other tactic recommendations, and cater presentations to their customers' interests. ClearView, the company's business intelligence platform, is designed specifically for the pharmaceutical industry, combining Field Force, Marketing and Managed Markets metrics and insights in one place. Pursuit's Data Management, Campaign Operations, and Strategy & Analytics capabilities enable its clients to take advantage of alignment across sales and marketing channels, so that customers have a valuable and consistent experience. Pursuit Solutions is headquartered in Chester, NJ, with offices in Boston, MA, and in the southern San Francisco and Orange County, CA areas. For more information, visit http://www.pursuit-solutions.com. Read the full story at http://www.prweb.com/releases/2014/08/prweb12108877.htm (c) 2014 PRWEB.COM Newswire |